Evidence map›Paper›PMID 36526322›Full record

ArticleBMJ open2022

Mapping care provision for type 1 diabetes throughout Australia: a protocol for a mixed-method study.

Ann Carrigan, Rebecca Lake, Sophia Zoungas, Tony Huynh, Jennifer Couper, Elizabeth Davis, Timothy Jones, David Bloom, Jeffrey Braithwaite, Yvonne Zurynski

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Ann CarriganAustralian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia.ORCID 0000-0002-2525-9241
Rebecca LakeAustralian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia.
Sophia ZoungasMonash Centre for Health Research and Implementation-MCHRI, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.ORCID 0000-0003-2672-0949
Tony HuynhDepartment of Endocrinology and Diabetes, Queensland Children's Hospital, South Brisbane, Queensland, Australia.
Jennifer CouperAdelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.
Elizabeth DavisDepartment of Endocrinology and Diabetes, Perth Children's Hospital, Nedlands, Western Australia, Australia.
Timothy JonesDepartment of Endocrinology and Diabetes, Perth Children's Hospital, Nedlands, Western Australia, Australia.
David BloomDepartment of Global Health and Population, Harvard School of Public Health, Boston, Massachusetts, USA.
Jeffrey BraithwaiteAustralian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia.ORCID 0000-0003-0296-4957
Yvonne ZurynskiAustralian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia yvonne.zurynski@mq.edu.au.ORCID 0000-0001-7744-8717
Macquarie University · AUThe Kids Research Institute Australia · AUHarvard Global Health Institute · USThe University of Adelaide · AUThe University of Queensland · AUThe University of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionType 1 diabetes (T1D) is a chronic and incurable autoimmune disease, diagnosed in early childhood and managed initially in paediatric healthcare services. In many countries, including Australia, national audit data suggest that management and care of T1D, and consequently glycaemic control, are consistently poor. This can lead to adverse outcomes such as cardiovascular disease and nephropathy. T1D treatment is complex, multidisciplinary, multiagency and life-long and should involve patient-centred, developmentally appropriate care. Although an emerging body of literature describes T1D models of care, their components, implementation determinants and associated outcomes are poorly understood.

objectivesTo provide a study protocol to describe methods to map existing models of care for children and young adults living with T1D. It will identify the gaps and needs in care delivery as viewed by healthcare providers and by children, young people and their families accessing care in metropolitan and rural or remote regions throughout Australia. METHODS AND ANALYSIS: A mixed-method study that includes provider and consumer-specific surveys and interviews about current T1D care provisions. Data will be analysed thematically (qualitative) and statistically (quantitative) and synthesised to describe the key characteristics of effective and sustainable models of care for T1D and to identify gaps. ETHICS AND DISSEMINATION: Ethics approval was granted by the Macquarie University Human Research Ethics Committee in July 2022 (#520221154439676). Results will be disseminated via publication in peer-reviewed journals and at relevant conferences.

Indexed as

Diabetes Mellitus, Type 1AdolescentAustraliaChildChild, PreschoolHealth PersonnelHumansResearch DesignYoung Adultgeneral endocrinologypaediatric endocrinologyquality in health care

Identifiers

PMID36526322
PMCPMC9764665
OpenAlexW4311693329

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.